Skip to main content
OpenTrials

Clinical trial condition

Myelofibrosis

Explore clinical trials studying Myelofibrosis. Study availability and eligibility vary by location and protocol.

175 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Myelofibrosis trial results

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis

NCT04679870

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • MD Andersson Cancer Hospital Houston, Texas, United States
  • Woden Dermatology Canberra, Australia
  • Heinrich-Heine-University Dusseldorf Düsseldorf, Germany
  • Universitätsklinikum Heidelberg Heidelberg, Germany
View Trial Details
Active, not recruiting

Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)

NCT03645824

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Gent-UZGENT Ghent, Belgium
  • BE-Leuven-UZLEUVEN Leuven, Belgium
  • BE-Roeselare-AZDELTA Roeselare, Belgium
View Trial Details
Completed

Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

NCT04676529

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Comprehensive Cancer Center (UAB CCC) Birmingham, Alabama, United States
  • Novant Health Cancer Institute Winston-Salem, North Carolina, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Liverpool Hospital Liverpool, New South Wales, Australia
View all 23 locations
View Trial Details
Completed

Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.

NCT03427866

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions